Mia Herdiyani Achmad, Reviono Reviono, Y. Sutanto, J. Aphridasari, Windu Prasetyo
{"title":"Is Vaccination Related to The Cure Rate of COVID-19 Patients with Comorbidities?","authors":"Mia Herdiyani Achmad, Reviono Reviono, Y. Sutanto, J. Aphridasari, Windu Prasetyo","doi":"10.36497/jri.v43i3.324","DOIUrl":null,"url":null,"abstract":"Background: Prior vaccination can prevent a COVID-19 patient from falling into moderate, severe, and critical conditions. The effect of vaccination on COVID-19 patients’ recovery has been widely studied. However, its correlation in critically severe COVID-19 patients with comorbidity has not been fully understood yet. This study aims to determine the correlation of vaccination in critically severe COVID-19 patients with comorbidity of hypertension and/or Diabetes Mellitus (DM).Methods: A retrospective cohort study was conducted in critically severe COVID-19 patients with hypertension and/or DM treated in Dr. Moewardi Hospital, Surakarta, Indonesia from March 2021 to September 2021. The data were taken from patients’ medical records. We analyzed all data statistically with Chi-Square and fisher's exact test, and a p-value of < 0.05 was considered significant.Results: There were 489 patients included in our study, 247 patients with hypertension and DM, and 242 patients without comorbidities. Vaccination status was significantly associated with the cure rate of critically severe COVID- 19 patients with hypertension (p=0.018), but not with DM (p=0.606). There was no significant association between age to the cure rate of critically severe COVID-19 patients with hypertension and DM (p=0.953). Vaccination status was related among patients with comorbidities and without comorbidities (p<0.001).Conclusion: Vaccination was significantly correlated the cure rate of moderate to critically severe COVID-19 patients with hypertension and without comorbidities.","PeriodicalId":168168,"journal":{"name":"Jurnal Respirologi Indonesia","volume":"112 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Respirologi Indonesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36497/jri.v43i3.324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Prior vaccination can prevent a COVID-19 patient from falling into moderate, severe, and critical conditions. The effect of vaccination on COVID-19 patients’ recovery has been widely studied. However, its correlation in critically severe COVID-19 patients with comorbidity has not been fully understood yet. This study aims to determine the correlation of vaccination in critically severe COVID-19 patients with comorbidity of hypertension and/or Diabetes Mellitus (DM).Methods: A retrospective cohort study was conducted in critically severe COVID-19 patients with hypertension and/or DM treated in Dr. Moewardi Hospital, Surakarta, Indonesia from March 2021 to September 2021. The data were taken from patients’ medical records. We analyzed all data statistically with Chi-Square and fisher's exact test, and a p-value of < 0.05 was considered significant.Results: There were 489 patients included in our study, 247 patients with hypertension and DM, and 242 patients without comorbidities. Vaccination status was significantly associated with the cure rate of critically severe COVID- 19 patients with hypertension (p=0.018), but not with DM (p=0.606). There was no significant association between age to the cure rate of critically severe COVID-19 patients with hypertension and DM (p=0.953). Vaccination status was related among patients with comorbidities and without comorbidities (p<0.001).Conclusion: Vaccination was significantly correlated the cure rate of moderate to critically severe COVID-19 patients with hypertension and without comorbidities.
背景:事先接种疫苗可以防止COVID-19患者陷入中度、重度和危重症。疫苗接种对COVID-19患者康复的影响已被广泛研究。然而,其在COVID-19合并合并症的危重型患者中的相关性尚不完全清楚。本研究旨在确定疫苗接种与合并高血压和/或糖尿病(DM)的COVID-19危重症患者的相关性。方法:对2021年3月至2021年9月在印度尼西亚苏拉arta Dr. Moewardi医院治疗的COVID-19合并高血压和/或糖尿病的危重患者进行回顾性队列研究。这些数据取自病人的医疗记录。我们采用卡方检验和fisher精确检验对所有数据进行统计学分析,p值< 0.05为显著性。结果:纳入489例患者,其中合并高血压和糖尿病247例,无合并症242例。疫苗接种情况与危重型COVID- 19合并高血压患者治愈率有显著相关性(p=0.018),与糖尿病无显著相关性(p=0.606)。COVID-19危重型高血压合并糖尿病患者的治愈率与年龄无显著相关性(p=0.953)。有合并症和无合并症患者的疫苗接种状况相关(p<0.001)。结论:接种疫苗与无合并症的中重度高血压患者的治愈率显著相关。